Injector tech could slash polio vaccine costs

A new needle-free injector technology that can deliver vaccine just under the skin among infants can provide a protective amount of polio vaccine with only a fifth of the recommended dosage. Investigators said that the breakthrough is particularly important for developing nations in need of low-cost vaccination programs. Story

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.